The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes for plasma-based comprehensive genomic profiling versus tissue testing in advanced lung adenocarcinoma.
 
Ray D. Page
Employment - The Center for Cancer and Blood Disorders
Honoraria - Cardinal Health
Consulting or Advisory Role - Amgen; AstraZeneca; Quality Cancer Care Alliance; Roche; Tesaro
Research Funding - AstraZeneca; celgene; E.R. Squibb Sons, LLC; Genentech; Gilead Sciences; Janssen; Lilly; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; Taiho Pharmaceutical; Takeda
 
Leylah Drusbosky
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Travel, Accommodations, Expenses - Guardant Health
 
Hiba I. Dada
Employment - Gilead Sciences (I); Guardant Health; Illumina
Stock and Other Ownership Interests - Gilead Sciences (I); Guardant Health; Illumina
 
Victoria M. Raymond
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Davey B. Daniel
Research Funding - Abbvie (Inst); Amgen (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); G1 Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health (Inst); Immunomedics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
 
Stephen G. Divers
No Relationships to Disclose
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Calithera Biosciences; Daiichi Sankyo/Lilly; EMD Serono; Genentech; Janssen Oncology; Lilly; Merck KGaA; Seagen; Takeda; Tesaro
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); ARIAD (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Elevation Oncology (Inst); Elevation Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Loxo (Inst); Pfizer (Inst); Seagen (Inst); Xcovery (Inst); Zeno Pharmaceuticals (Inst)
 
Miguel Angel Villalona-Calero
Stock and Other Ownership Interests - Moderna Therapeutics; regeneron
Consulting or Advisory Role - Lilly
Research Funding - Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Guardant Health (Inst); Merck (Inst); Novocure (Inst); Tolero Pharmaceuticals (Inst)
 
Justin Iver Odegaard
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Richard B. Lanman
Employment - Guardant Health
Leadership - Biolase; Guardant Health
Stock and Other Ownership Interests - Biolase; Forward; Guardant Health
Consulting or Advisory Role - Forward; Guardant Health
Research Funding - Guardant Health
 
Vassiliki Papadimitrakopoulou
Employment - Pfizer
Honoraria - Roche
Consulting or Advisory Role - Abbvie; Araxes Pharma; ARIAD; Arrys Therapeutics; AstraZeneca; Biothera; Bolt Biotherapeutics; Bristol-Myers Squibb; Clovis Oncology; Exelixis; G2 Innovation; Genentech; Genentech; Gritstone Bio; Janssen; Leads Biolabs; Lilly; Loxo; Merck; Nektar; Novartis; Pfizer; Takeda; Tesaro; TRM Oncology
Research Funding - ACEA Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkmate Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Clovis Oncology (Inst); Guardant Health (Inst); Incyte (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Roche
Other Relationship - Roche
 
Natasha B. Leighl
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Xcovery
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Roche